Is Helix BioPharma Corp. (HBP.TO) a Buy, Sell, or Hold?
TSX : HBP.TO
Helix BioPharma Corp. — Competitors
$1.4 CAD
$0 (0.0%)
- Volume
- 2.34K
- Average Volume
- 1.4K
- Market Capitalization
- $106.93M
- P/E Ratio
- -31.82
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $5.40
- Year Low
- $0.95
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.45
HBP.TO vs. The Competition
| Properties | HBP.TO | CRDL.TO | CYBN.NE | HLS.TO |
|---|---|---|---|---|
| Market Cap | $106.93M | $204.61M | $269.89M | $130.73M |
| Shares Outstanding | $76.38M | $115.27M | $24.21M | $31.27M |
| P/E Ratio | -31.82 | -4.54 | -1.92 | -9.34 |
| EPS | -0.04 | -0.33 | -2.92 | -0.33 |
| Day Low | 1.1 | 1.74 | 10.8 | 4.16 |
| Day High | 1.435 | 1.82 | 11.39 | 4.2 |
| Year Low | 0.95 | 1.225 | 5.3 | 0.001 |
| Year High | 5.4 | 2.33 | 15.27 | 5.765 |
| Average Price 50 | 1.5062 | 1.617 | 9.2786 | 4.3973 |
| Average Price 200 | 1.9901 | 1.54518 | 9.6008 | 4.70083 |
| Volume | 2340 | 78338 | 20849 | 6800 |
| Average Volume | - | - | - | - |